These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12365601)

  • 21. [Preparation and utility of glibenclamide suppository for hospital use].
    Takahashi Y; Iwata M; Shirotake S; Takayama K; Machida Y; Nagai T
    Yakugaku Zasshi; 1998 Sep; 118(9):401-7. PubMed ID: 9779000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Arrieta F; Herrera JL
    Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
    [No Abstract]   [Full Text] [Related]  

  • 23. Rectal insulin: a potent hypoglycemic preparation.
    Bakth S; Ertel NH; May PB; Akgun S
    Horm Metab Res; 1980 Feb; 12(2):86-7. PubMed ID: 6989733
    [No Abstract]   [Full Text] [Related]  

  • 24. Availability of oxyphenbutazone from different suppository formulations.
    Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
    Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability assessment of salbutamol sulfate suppositories in human volunteers.
    Taha EI; Zaghloul AA; Samy AM; Al-Saidan S; Kassem AA; Khan MA
    Int J Pharm; 2004 Jul; 279(1-2):3-7. PubMed ID: 15234788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative 35Cl nuclear quadrupole resonance in tablets of the antidiabetic medicine Diabinese.
    Tate E; Althoefer K; Barras J; Rowe MD; Smith JA; Pearce GE; Wren SA
    Anal Chem; 2009 Jul; 81(13):5574-6. PubMed ID: 19492808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of mucin as a release enhancer for rectal delivery of glibenclamide.
    Adikwu MU; Okafor JO
    Curr Drug Deliv; 2006 Jul; 3(3):243-54. PubMed ID: 16848726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR search for polymorphic phase transformations in chlorpropamide form-A at high pressures.
    Wasicki J; Kozlenko DP; Pankov SE; Bilski P; Pajzderska A; Hancock BC; Medek A; Nawrocik W; Savenko BN
    J Pharm Sci; 2009 Apr; 98(4):1426-37. PubMed ID: 18623194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations.
    Zidan AS; Emam SE; Shehata TM; Ghazy FE
    AAPS PharmSciTech; 2015 Jun; 16(3):645-55. PubMed ID: 25501871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
    Kosior A
    Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of snail mucin motifs as rectal absorption enhancer for insulin in non-diabetic rat models.
    Adikwu MU
    Biol Pharm Bull; 2005 Sep; 28(9):1801-4. PubMed ID: 16141566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin availability from mucoadhesive tablets.
    Pluta J; Haznar D; Suszka-Switek A; Ryszka F
    Pharmazie; 2008 Sep; 63(9):650-3. PubMed ID: 18819517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of microneedles for percutaneous absorption of insulin.
    Ito Y; Hagiwara E; Saeki A; Sugioka N; Takada K
    Eur J Pharm Sci; 2006 Sep; 29(1):82-8. PubMed ID: 16828268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of surfactant incorporation techniques on sulphamethoxazole suppository formulations.
    Abd el-Gawad AH; el-Din EZ; Abd el-Alim HA
    Pharmazie; 1988 Sep; 43(9):624-7. PubMed ID: 3244731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between pharmacokinetic and pharmacodynamic parameters of chlorpropamide administered to rabbits. II].
    Vila JL; Dominguez-Gil AA
    Boll Chim Farm; 1980 Jun; 119(6):355-60. PubMed ID: 7459053
    [No Abstract]   [Full Text] [Related]  

  • 40. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
    Bećirević M; Petricić V
    Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.